Dilara Perver

Dr. Dilara Perver is a Lecturer and Jr. Group Leader at ETH Zürich, affiliated with the Department of Health Sciences and Technology and the Institute of Translational Medicine. She holds a Dr. Sc. ETH Zürich, complemented by M.Sc. degrees in Biology and Chemistry from Hacettepe University (Turkey). Her research focuses on ex-vivo technologies for immuno-cellular therapies targeting hematological malignancies, predictive microphysiological models for leukemia/lymphoma, and development of bioreactors for stem cell expansion. She has authored numerous peer-reviewed articles and book chapters, with a particular emphasis on bone marrow niche engineering and extracellular matrix dynamics.

Key professional milestones include a postdoctoral role at ETH Zürich, an internship at Novartis in CAR-T cell therapy development, and leadership roles in academic associations like AVETH and the Scientific Staff Association of Health Sciences and Technology. She has secured grants such as the TÜBİTAK Doctoral Research Grant (USD 120,000) and the National Graduate Student Prestige Scholarship. Her work bridges biomaterials, stem cell biology, and clinical translation, with implications for regenerative medicine and oncology.

Dr. Perver is actively involved in teaching and science communication, having completed training in project management, entrepreneurship, and clinical trial design. Her contributions to interdisciplinary research and innovation are further highlighted by her memberships in societies like the International Society for Stem Cell Research (ISSCR) and the European Society for Blood and Marrow Transplantation (EBMT).